SCI Abstract

search
+
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center
Pseudohyperkalemia (falsely elevated serum potassium) must be distinguished from true hyperkalemia to avoid unnecessary tr...
Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance
Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance
Approximately 7% of patients with newly diagnosed multiple myeloma (MM) experience bleeding complications with varying cau...
Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab
Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab
Paroxysmal cold hemoglobinuria (PCH) is a form of cold autoimmune hemolytic anemia characterized by the presence of the Do...
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag
Romiplostim, a thrombopoietin (TPO) receptor agonist, is a clinically approved drug that is clearly effective in reconstit...
Pathological landscape of tumor flare reaction to epcoritamab treatment
Pathological landscape of tumor flare reaction to epcoritamab treatment
Tumor flare reaction (TFR) is characterized by an increase in lesion size during immune-based therapy, often resembling di...
Precision medicine in AML: overcoming resistance
Precision medicine in AML: overcoming resistance
The development of molecularly targeted therapy for acute myeloid leukemia is progressing at an accelerated pace. Therapie...
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm
We extend our deepest appreciation to the entire medical team at Yokohama Municipal Citizen's Hospital for their unwaverin...
Trametinib for a child with refractory Rosai–Dorfman–Destombes disease harboring a novel somatic mutation in MAP2K1
Trametinib for a child with refractory Rosai–Dorfman–Destombes disease harboring a novel somatic mutation in MAP2K1
Rosai–Dorfman–Destombes disease (RDD) is a rare histiocytosis characterized by accumulation of S100 +...
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
Acquired hemophilia A (AHA) is a rare bleeding disorder caused by autoantibodies inhibiting human factor VIII (hFVIII). Th...
CAR-T cell therapy in AML: recent progress and future perspectives
CAR-T cell therapy in AML: recent progress and future perspectives
Despite several small-molecule drugs that have revolutionized the current treatment strategy for acute myeloid leukemia (A...
Bilateral development of biclonal ocular adnexal marginal zone lymphoma at a 2-year interval
Bilateral development of biclonal ocular adnexal marginal zone lymphoma at a 2-year interval
Ocular adnexal marginal zone B-cell lymphoma (OAMZL) of the mucosa-associated lymphoid tissue is a distinct subtype of B-c...
A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial)
A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial)
Although bosutinib is generally safe and effective, drug-related toxicities (DRTs) such as diarrhea or increased transamin...
Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan
Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan
Autoimmune factor XIII (FXIII) deficiency (AiF13D) is a rare hemorrhagic disease. The anti-FXIII autoantibodies that cause...
Molecular pathophysiology of germline mutations in acute myeloid leukemia
Molecular pathophysiology of germline mutations in acute myeloid leukemia
Germline (GL) predisposition to acute myeloid leukemia (AML) has been established as an independent disease entity in the ...
Metabolic dependencies of acute myeloid leukemia stem cells
Metabolic dependencies of acute myeloid leukemia stem cells
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy primarily driven by an immature population of AML c...
JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL
JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL
Conflict of interest KI has received per diem, including sp...
Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation
Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation
Criteria for airflow obstruction (AFO) at one year after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in...
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio
We conducted a multi-institutional retrospective study in 100 transplant-ineligible (TI) patients with diffuse large B-cel...
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)
The emergence of novel drugs has significantly improved outcomes of patients with plasma cell neoplasms (PCN). The Japanes...
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease
Relapsed and refractory (R/R) idiopathic multicentric Castleman disease (iMCD) is a clinical challenge with no standard tr...
Platelet and large platelet ratios are useful in predicting severity of COVID-19
Platelet and large platelet ratios are useful in predicting severity of COVID-19
The role of platelets in coronavirus disease (COVID-19) severity requires further exploration. To determine whether the pl...
Honeycomb lung appearance accompanied by pediatric Langerhans cell histiocytosis: changes in imaging findings following chemotherapy
Honeycomb lung appearance accompanied by pediatric Langerhans cell histiocytosis: changes in imaging findings following chemotherapy
Cite this articleSakamoto, K., Miyazaki, O. & Shioda, Y. Honeycomb lung appearance accompanied by pediatric Langerhans...
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid
As multiple myeloma (MM) progresses, immune effector cells decrease in number and function and become exhausted. This rema...
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
NS-87/CPX-351 is a dual-drug liposomal encapsulation of cytarabine and daunorubicin. NS-87/CPX-351 exerts antileukemic act...
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era
Guidelines recommend rasburicase for high-risk patients to prevent tumor lysis syndrome (TLS). However, little information...
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial
Response determined by 18[F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron emission tomography (PET)–CT after inductio...
Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma
Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma
Intravascular large B-cell lymphoma (IVLBCL), a rare subtype of malignant lymphoma, is diagnosed by observation of intrava...
Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study
Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study
The dosage of chemotherapy drugs for overweight/obese children with acute myeloid leukemia (AML) has been empirically redu...
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan
Myeloid and lymphoid neoplasms associated with FGFR1 abnormalities (MLN-FGFR1 abnormalities) are rare hematologic malignan...
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome
Allogenic hematopoietic stem cell transplantation (allo-HSCT) is not a standard therapy for solid cancer because of its hi...
Load More
format_indent_increase